HEALTH CARE RESOURCE UTILIZATION AND ASSOCIATED COSTS AMONG LOWER-RISK MYELODYSPLASTIC SYNDROME PATIENTS IN FRANCE: EDELWEISS STUDY

被引：0
|
作者：
Comont, T. [1 ]
Fernandes, J. [2 ]
Chartier, M. [3 ]
Cotte, F. E. [4 ]
Pages, N. [5 ]
Panes, A. [5 ]
Schmidt, A. [5 ]
Webert, L. [3 ]
D. Aveni-Piney, M. [6 ]
机构：
[1] CHU Toulouse, Toulouse, France
[2] Ctr Hosp Cote Basque, Bayonne, France
[3] Bristol Myers Squibb, Rueil Malmaison, France
[4] Bristol Myers Squibb, Rueil Malmaison 92, France
[5] HEVA, Lyon, France
[6] CHRU Nancy, Nancy, France
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
SA67
引用
收藏
页码：S627 / S627
页数：1
相关论文
共 50 条
  • [21] Health care utilization and costs in patients with early onset myelodysplastic syndrome in a commercially insured population
    Powers, A.
    Stein, K.
    Knoth, R. L.
    Broder, M.
    Chang, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [22] Integrating Care for Patients With Lower Risk Myelodysplastic Syndrome
    Garcia-Manero, Guillermo
    SEMINARS IN ONCOLOGY, 2011, 38 (05) : 658 - 666
  • [23] Validation of the Lower-Risk MD Anderson Prognostic Scoring System for Patients With Myelodysplastic Syndrome
    Komrokji, Rami
    Ramadan, Hanadi
    Al Ali, Najla
    Corrales-Yepez, Maria
    Zhang, Ling
    Padron, Eric
    Lancet, Jeffrey
    List, Alan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S60 - S63
  • [24] Evaluation of Parameters Related to the Probability of Leukemic Progression in Patients With Lower-Risk Myelodysplastic Syndrome
    Falantes, Jose F.
    Marquez-Malaver, Francisco J.
    Calderon-Cabrera, Cristina
    Pedrote, Begona
    Martino, Maria L.
    Gonzalez, Jose
    Espigado, Ildefonso
    Perez-Simon, Jose A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (07): : 469 - +
  • [25] Clinical Outcomes, Survival, and Predictors in Lower-Risk Myelodysplastic Syndrome Patients Treated with Cyclosporine A
    Lu, Yingjia
    Zhang, Lina
    Qu, Weiying
    Feng, Zhou
    Deng, Yuan
    Zhao, Lin
    ACTA HAEMATOLOGICA, 2024, 147 (06) : 716 - 728
  • [26] Health Care Resource Utilization and Costs Among Eosinophilic Esophagitis Patients in the United States
    Chehade, Mirna
    Epstein, Andrew J.
    McCann, Eilish
    Tilton, Sarette T.
    Nag, Arpita
    Chen, Chao
    Wang, Degang
    Pela, Tiffany
    Khodzhayev, Angela
    Thomas, Ryan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S274 - S275
  • [27] Combination Therapy of Eltrombopag and Cyclosporine a Improves Hematopoiesis in Patients with Lower-Risk Myelodysplastic Syndrome
    Song, Luxi
    Chang, Chunkang
    Wang, Jianxiang
    BLOOD, 2022, 140 : 4084 - 4085
  • [28] HEALTH CARE COSTS AND RESOURCE UTILIZATION IN ELDERLY PATIENTS WITH HIGH RISK VASCULAR DISEASE
    Zhao, Z.
    Zhu, Y.
    Fang, Y.
    McCollam, P.
    VALUE IN HEALTH, 2014, 17 (03) : A111 - A111
  • [29] Retrospective Case Series Study of Hypomethylating Therapy in IPSS Lower-Risk Myelodysplastic Syndrome
    Park, Han-Seung
    Lee, Je-Hwan
    Kim, Yoo-Jin
    Sohn, Sang Kyun
    Yoon, Sung-Soo
    Kim, Hawk
    Cheong, June-Won
    Lee, Won-Sik
    Lee, Gyeong-Won
    Joo, Young-Don
    Kim, Min Kyoung
    Kim, Yang Soo
    Kim, Hyeoung-Joon
    BLOOD, 2016, 128 (22)
  • [30] Multivariable Time-Dependent Analysis Of The Impact Of 5 Azacitidine In Patients With Lower-Risk Myelodysplastic Syndrome and Unfavorable Specific Lower-Risk Score
    Falantes, Jose F.
    Garcia Delgado, Regina
    Calderon, Cristina
    Valcarcel, David
    Montoro, Julia
    De Miguel, Dunia
    Malaver, Francisco J. Marguez
    Bailen, Alicia
    Bargay, Joan
    Bernal, Teresa
    Gonzalez-Porras, Jose R.
    Tormo, Mar
    Ramos, Fernando
    Andreu, Rafael
    Xicoy, Blanca
    Nomdedeu, Benet
    Brunet, Salut
    Sanchez, Joaquin
    Juradels, Antonio Fernandez
    Bonanad, Santiago
    Espigado, Ildefonso
    Perez-Simon, Jose Antonio
    Sanz, Guillermo
    BLOOD, 2013, 122 (21)
12345